April 26, 2021, the State Food and Drug Administration issued a notice, Hunan Dongting Pharmaceutical Co., LTD clozapine tablets successfully approved! This variety is completed by Duzheng Biological "one-stop" clinical research. (Hunan Brain Hospital, co-built by the company, is responsible for the clinical, the smart recruitment, the first leading medicine is responsible for THE SMO service, and the data management and statistical analysis of farmed data), which is also the second clozapine tablet approved by the company.
Clozapine tablet, indications for this product is not only effective on positive symptoms of mental illness, negative symptoms also have a certain effect. It is suitable for all subtypes of acute and chronic schizophrenia, and has good effect on hallucinations and delusions. It is also used to treat hypomania or other psychotic disorders of agitation and delusions.
According to Minae Database, the annual sales of clozapine tablets in urban public hospitals in 2019 amounted to 99.38 million yuan. IQVIA database shows that hospitals purchased about 140 million yuan of oral tablets in 2019.
As a "one-stop" service platform for clinical research, Duzheng Biology has been relying on rich clinical research experience, scientific scheme design and strict clinical control to adhere to the use of clinical data to restore the truth, helping a number of pharmaceutical companies successfully approved! Realize the curve overtaking, seize the drug market.
At present, several projects are under development.